(Q38076755)

English

Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications

scientific article published on 28 January 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

0 references

author name string

Mitchell L Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Catherine Tomaro-Duchesneau

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Christopher J Martoni

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Satya Prakash

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

language of work or name

0 references

publication date

28 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

631-642

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

A review of the cost of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

"The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Pharmacological strategies for lowering LDL cholesterol: statins and beyond

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Triglycerides and the Risk of Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The problem of compliance to cholesterol altering therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Simvastatin with or without ezetimibe in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Extended-release niacin or ezetimibe and carotid intima-media thickness.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bile salt transporters: molecular characterization, function, and regulation

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Health benefits and health claims of probiotics: bridging science and marketing

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Human gut microbiota and its relationship to health and disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Enterotypes of the human gut microbiome

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Probiotics and human health: a clinical perspective

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Probiotics as oral health biotherapeutics

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The role of the gut microbiota in energy metabolism and metabolic disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bifidobacterium animalis strain DN-173 010 hydrolyses bile salts in the gastrointestinal tract of pigs

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Cloning and characterization of the bile salt hydrolase genes (bsh) from Bifidobacterium bifidum strains

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bile salt hydrolase activity of Enterococci isolated from food: screening and quantitative determination

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Purification and characterization of a new hydrolase for conjugated bile acids, chenodeoxycholyltaurine hydrolase, from Bacteroides vulgatus

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Probiotic capsules do not lower plasma lipids in young women and men.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effects of consumption of probiotics and prebiotics on serum lipid levels in humans

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bile salt hydrolase activity in probiotics.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Targeting bile-acid signalling for metabolic diseases

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 Promote Cholesterol Excretion Through the Up-Regulation of ABCG5/8 in Caco-2 Cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Bile acids stimulate ATP hydrolysis in the purified cholesterol transporter ABCG5/G8.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The hypocholesterolaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-like 1.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Apolipoprotein B synthesis inhibition: results from clinical trials

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Regulation of cholesterol metabolism by dietary plant sterols

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Effects of long term plant sterol and -stanol consumption on the retinal vasculature: A randomized controlled trial in statin users

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Scientific Opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924/2006

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Cholesterol-lowering effects of oat β-glucan

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758706

21 January 2018

Identifiers

10.1517/14712598.2013.758706

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38076755&oldid=2133631843"